5 Key Takeaways

• 1

  The FYSX Ocular Pressure Adjusting Pump is the first FDA-approved nonpharmacological, nonsurgical treatment for glaucoma.

• 2

  FYSX effectively lowers intraocular pressure (IOP) in patients with low or normal eye pressure, achieving a mean IOP reduction of 39%.

• 3

  The device uses negative pressure within goggles worn during sleep to create a microenvironment that reduces IOP.

• 4

  FYSX allows for personalized therapy by tracking usage, enabling adjustments based on individual patient needs.

• 5

  This innovative approach offers an alternative to traditional filtering procedures, which have inconsistent outcomes and safety concerns.